OMNIDAB
Live / Registered — Registered (as of 11 Nov 2025)
What this means for you
Registered since 11 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98120280
- Registration number
- 8024291
- Mark type
- Design + words
- Filed
- 07 Aug 2023
- Published for opposition
- 11 Jun 2024
- Registered
- 11 Nov 2025
- Attorney of record
- Francis P. Cislak
Goods and services
- Class 001 — Chemicals: Antibodies for use in further scientific and medical research
- Class 042 — Scientific and technological services: Scientific research and development; scientific research and development in the field of immunization and antibody screening
Owner
- OMNIAB, INC., Emeryville, CA, US
- OMNIAB, INC., Emeryville, CA, US
- OMNIAB, INC., Emeryville, CA, US
Prior registrations
Prosecution history
- 11 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 06 Nov 2025 — ASSIGNED TO EXAMINER
- 23 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Oct 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 09 Oct 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 09 Oct 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 12 Jul 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 12 Jul 2025 — FINAL REFUSAL E-MAILED
- 12 Jul 2025 — SU - FINAL REFUSAL - WRITTEN
- 03 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE